297 related articles for article (PubMed ID: 21389972)
1. Erythropoiesis-stimulating agents increase the risk of acute stroke in patients with chronic kidney disease.
Seliger SL; Zhang AD; Weir MR; Walker L; Hsu VD; Parsa A; Diamantidis CJ; Fink JC
Kidney Int; 2011 Aug; 80(3):288-94. PubMed ID: 21389972
[TBL] [Abstract][Full Text] [Related]
2. Timing of erythropoiesis-stimulating agent initiation and adverse outcomes in nondialysis CKD: a propensity-matched observational study.
Seliger S; Fox KM; Gandra SR; Bradbury B; Hsu VD; Walker L; Chiou CF; Fink JC
Clin J Am Soc Nephrol; 2010 May; 5(5):882-8. PubMed ID: 20299377
[TBL] [Abstract][Full Text] [Related]
3. Initiation of anaemia management in patients with chronic kidney disease not on dialysis in the Veterans Health Administration.
Lawler EV; Gagnon DR; Fink J; Seliger S; Fonda J; Do TP; Gaziano JM; Bradbury BD
Nephrol Dial Transplant; 2010 Jul; 25(7):2237-44. PubMed ID: 20083469
[TBL] [Abstract][Full Text] [Related]
4. Dose of erythropoiesis-stimulating agents and adverse outcomes in CKD: a metaregression analysis.
Koulouridis I; Alfayez M; Trikalinos TA; Balk EM; Jaber BL
Am J Kidney Dis; 2013 Jan; 61(1):44-56. PubMed ID: 22921639
[TBL] [Abstract][Full Text] [Related]
5. Testosterone deficiency is a cause of anaemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney disease.
Carrero JJ; Bárány P; Yilmaz MI; Qureshi AR; Sonmez A; Heimbürger O; Ozgurtas T; Yenicesu M; Lindholm B; Stenvinkel P
Nephrol Dial Transplant; 2012 Feb; 27(2):709-15. PubMed ID: 21617198
[TBL] [Abstract][Full Text] [Related]
6. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
Maddux FW; Shetty S; del Aguila MA; Nelson MA; Murray BM
Ann Pharmacother; 2007 Nov; 41(11):1761-9. PubMed ID: 17895328
[TBL] [Abstract][Full Text] [Related]
7. In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: a population-based study.
Ingrasciotta Y; Lacava V; Marcianò I; Giorgianni F; Tripepi G; D' Arrigo G; Chinellato A; Ugo Tari D; Santoro D; Trifirò G
BMC Nephrol; 2019 Sep; 20(1):359. PubMed ID: 31521117
[TBL] [Abstract][Full Text] [Related]
8. Role of residual renal function in phosphate control and anemia management in chronic hemodialysis patients.
Penne EL; van der Weerd NC; Grooteman MP; Mazairac AH; van den Dorpel MA; Nubé MJ; Bots ML; Lévesque R; ter Wee PM; Blankestijn PJ;
Clin J Am Soc Nephrol; 2011 Feb; 6(2):281-9. PubMed ID: 21030579
[TBL] [Abstract][Full Text] [Related]
9. Erythropoiesis-stimulating agent slows the progression of chronic kidney disease: a possibility of a direct action of erythropoietin.
Tsuruya K; Yoshida H; Suehiro T; Fujisaki K; Masutani K; Kitazono T
Ren Fail; 2016; 38(3):390-6. PubMed ID: 26822074
[TBL] [Abstract][Full Text] [Related]
10. Trends in anemia management in lung and colon cancer patients in the US Department of Veterans Affairs, 2002-2008.
Tarlov E; Stroupe KT; Lee TA; Weichle TW; Zhang QL; Michaelis LC; Ozer H; Browning MM; Hynes DM
Support Care Cancer; 2012 Aug; 20(8):1649-57. PubMed ID: 21935718
[TBL] [Abstract][Full Text] [Related]
11. Impact of pharmacist-managed erythropoiesis-stimulating agents clinics for patients with non-dialysis-dependent CKD.
Aspinall SL; Cunningham FE; Zhao X; Boresi JS; Tonnu-Mihara IQ; Smith KJ; Stone RA; Good CB;
Am J Kidney Dis; 2012 Sep; 60(3):371-9. PubMed ID: 22633556
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for high erythropoiesis stimulating agent resistance index in pre-dialysis chronic kidney disease patients, stages 4 and 5.
de Lurdes Agostinho Cabrita A; Pinho A; Malho A; Morgado E; Faísca M; Carrasqueira H; Silva AP; Neves PL
Int Urol Nephrol; 2011 Sep; 43(3):835-40. PubMed ID: 20640598
[TBL] [Abstract][Full Text] [Related]
13. Treatment of anemia with erythropoietin-stimulating agents in kidney transplant recipients and chronic kidney disease-another drawback of immunosuppression?
Malyszko J; Glowinska I; Mysliwiec M
Transplant Proc; 2012 Dec; 44(10):3013-6. PubMed ID: 23195016
[TBL] [Abstract][Full Text] [Related]
14. Individualizing decision-making--resurrecting the doctor-patient relationship in the anemia debate.
Agarwal R
Clin J Am Soc Nephrol; 2010 Jul; 5(7):1340-6. PubMed ID: 20448071
[TBL] [Abstract][Full Text] [Related]
15. Transfusion burden among patients with chronic kidney disease and anemia.
Lawler EV; Bradbury BD; Fonda JR; Gaziano JM; Gagnon DR
Clin J Am Soc Nephrol; 2010 Apr; 5(4):667-72. PubMed ID: 20299366
[TBL] [Abstract][Full Text] [Related]
16. Soluble Fas affects erythropoiesis in vitro and acts as a potential predictor of erythropoiesis-stimulating agent therapy in patients with chronic kidney disease.
Chiloff DM; de Almeida DC; Dalboni MA; Canziani ME; George SK; Morsi AM; El-Akabawy N; Porada CD; Durao MS; Zarjou A; Almeida-Porada G; Goes MA
Am J Physiol Renal Physiol; 2020 Apr; 318(4):F861-F869. PubMed ID: 32003597
[TBL] [Abstract][Full Text] [Related]
17. End of an era of administering erythropoiesis stimulating agents among Veterans Administration cancer patients with chemotherapy-induced anemia.
Hoque S; Chen BJ; Schoen MW; Carson KR; Keller J; Witherspoon BJ; Knopf KB; Yang YT; Schooley B; Nabhan C; Sartor O; Yarnold PR; Ray P; Bobolts L; Hrushesky WJ; Dickson M; Bennett CL
PLoS One; 2020; 15(6):e0234541. PubMed ID: 32584835
[TBL] [Abstract][Full Text] [Related]
18. Anemia Prevalence, Type, and Associated Risks in a Cohort of 5.0 Million Insured Patients in the United States by Level of Kidney Function.
Farrington DK; Sang Y; Grams ME; Ballew SH; Dunning S; Stempniewicz N; Coresh J
Am J Kidney Dis; 2023 Feb; 81(2):201-209.e1. PubMed ID: 36181996
[TBL] [Abstract][Full Text] [Related]
19. Erythropoiesis stimulating agents and reno-protection: a meta-analysis.
Elliott S; Tomita D; Endre Z
BMC Nephrol; 2017 Jan; 18(1):14. PubMed ID: 28077085
[TBL] [Abstract][Full Text] [Related]
20. Risk for anemia in pediatric chronic kidney disease patients: a report of NAPRTCS.
Atkinson MA; Martz K; Warady BA; Neu AM
Pediatr Nephrol; 2010 Sep; 25(9):1699-706. PubMed ID: 20464428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
